Business Analysis News 10 October 2025

Nokia Stock Skyrockets on Major 5G Contracts – Analysts Eye Upside

Recent Stock Run-Up and Market Context Nokia’s stock has roared higher in October, buoyed by a string of positive catalysts. The ADR (ticker NOK on NYSE) jumped roughly 14% in early October, briefly touching about $5.49 on Oct. 14 ts2.tech.

23 October 2025

iPhone 17 Air vs Samsung Galaxy Z Flip 6 vs Google Pixel Fold 2: Apple’s Slim Marvel Faces Foldable Rivals

Apple Slashes iPhone Air Production Amid Disappointing Sales – What’s Next for AAPL?

Apple began informing its suppliers this week of new production plans: overall iPhone 17 output remains about 85–90 million units, but iPhone Air units will be sharply curtailed. A Nikkei/Verge scoop notes the Air’s share (originally ~10–15% of initial production)

23 October 2025

Apple · Business Analysis · iPhone · Stock Market · Technology News

Nebius Group Explodes 350% on AI Boom – Microsoft Deal and Earnings Next Week in Spotlight

Nebius Group is a Netherlands-based tech firm (spun out of Yandex in 2022) that provides full-stack AI cloud infrastructure. Its high-performance GPU data centers and software help clients (like Cloudflare and Shopify) train and run machine-learning models ts2.tech. CEO Arkady

22 October 2025

Artificial Intelligence · Business Analysis · Earnings Reports · NASDAQ:NBIS · Stock Market · Technology News

Navan’s $6.5B IPO Set for Takeoff – TravelTech Unicorn Aims High, But Will It Deliver?

Navan is a Palo Alto–based travel and expense management platform (formerly TripActions) that has expanded beyond corporate travel booking into payments and expense software. Its October IPO marks one of the first large travel-tech listings in 2025, aiming to capitalize

21 October 2025

Business Analysis · Financial Markets · IPO News · NASDAQ:NAVN · TravelTech · Unicorn Startups

Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Stock Performance: From Slump to Sudden Surge ts2.techLiberty Energy’s stock has seen a dramatic swing in recent weeks. After grinding lower for most of 2025 – at one point down over 40% year-to-date – LBRT caught a bid in October,

17 October 2025

Business Analysis · Earnings Reports · Energy · NYSE:LBRT · Oil & Gas · Stock Market

Nebius (NBIS) Stock Rockets on $17B Microsoft AI Deal – Explosive Growth & Outlook Revealed

Nebius Group (NBIS) Skyrockets 350% on AI Deal, Then Stumbles – What’s Next for This Cloud Newcomer?

Nebius Stock’s Wild 2025 Ride – From $14 to $130+ 🚀 Nebius Group’s logo on display – the AI cloud upstart has seen its stock skyrocket in 2025 amid major deals. Few stocks captured the AI frenzy of 2025 like

17 October 2025

Artificial Intelligence · Business Analysis · Cloud Computing · NASDAQ:NBIS · Stock Market · Technology News

Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle’s $300B AI Cloud Bet Sends Stock Soaring – Trillion-Dollar Dreams Awaken

Oracle Stock Update: Riding High on AI Frenzy Oracle headquarters building. Oracle’s stock has been a standout performer in 2025 amid a frenzy for AI-related cloud services. Oracle’s stock price is hovering near $304 per share as of October 17,

17 October 2025

Artificial Intelligence · Business Analysis · Cloud Computing · NYSE:ORCL · Stock Market · Technology News

Linkage Global (LGCB) Stock Doubles on Funding Lifeline – Can the E-Commerce Underdog Sustain the Rally?

Stock Price Volatility Amid Funding News Linkage Global’s stock has been on a rollercoaster, catapulting upward in recent sessions. On Thursday Oct. 16, LGCB nearly doubled in pre-market action, reaching around $3 per share stockanalysis.com. This spike followed an after-hours

16 October 2025

Business Analysis · E-Commerce · Investment News · Market Trends · NASDAQ:LGCB · Stock Market

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Deal Details: Novo Licenses Omeros’s MASP-3 Inhibitor On Oct. 15, Novo Nordisk and Seattle-based Omeros announced a definitive asset purchase and license agreement. Under the terms, Novo gains exclusive global rights to zaltenibart (OMS906) for all indications. Omeros will receive $340

15 October 2025

Biotech Industry · Business Analysis · Mergers & Acquisitions · NASDAQ:AKRO · NASDAQ:OMER · NYSE:NVO · Pharma News · Rare Diseases

ZIM Stock Rebounds as Shipping Giant Navigates Trade Turbulence

Stock Rebound Off Lows ZIM’s share price has shown signs of life after a prolonged slide. On October 14, the stock surged about 5% intraday, closing at approximately $13.36 (up from $12.72 the prior day) intellectia.ai. This pop extends a

14 October 2025

Business Analysis · Investment Insights · NYSE:ZIM · Shipping Industry · Stock Market · Trade News

BLS International Faces Govt Ban: Shares Plunge 18% – Analysts See 100% Upside?

MEA’s Shocking 2-Year Ban on BLS International – Visa Outsourcer’s Future in Doubt

MEA Ban Details and Reasoning Late on Oct 9 the Indian government quietly issued the order debaring BLS International from new MEA contracts ts2.tech. The company disclosed this in an Oct 11 exchange filing. The MEA order cites “complaints and

14 October 2025

Business Analysis · Government Policies · International Affairs · Travel News · Visa Services

Rocket Lab Rockets to New Heights on Huge Japan Deals – Is the Boom Sustainable?

Rocket Lab’s dramatic rise reflects both tech execution and a booming small-satellite market. As of early Oct 2025, RKLB trades near $70 (Nasdaq close $66.42 on Oct 9 stockanalysis.com), compared to the low-$50s in late September stockanalysis.com. The company’s Electron

10 October 2025

Aerospace Innovation · Business Analysis · Japan Partnerships · Rocket Launches · Space Industry

Business Analysis News 10 October 2025 - 23 October 2025